FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

RPGLIFE Share Price Discussion

RPG Life Sciences Ltd.
NSE: RPGLIFE | BSE: 532983 | ISIN: INE105J01010 | Sector: Pharmaceuticals and health care
ROHAN > RPGLIFE > Post
R
Reputation: 18,137 • May 27, 2020 5:09 AM

Type
Buy
Instrument
RPGLIFE
Entry Price
₹237
Price@Trade
₹236.5
Target Price
₹290
Stop Price
₹231  ₹250
Valid Till
May 27, 2021 3:20 AM
Margin
₹23,700 approx for 100 Qty
Status
Exited
Exit Price
₹251
Net P&L
+₹1,400 (+5.91%)
Like
Reply (3)
NSE:RPGLIFE price when posted: 236.5
3 Replies
TrackerBot @trackerbot
May 27, 2020 5:12 AM

Update
Trade Entered
Entry Price
₹237
ROHAN @rohan9401
May 29, 2020 7:30 AM

Update
Stoploss Trailed
Price @ Update
₹253
Original SL
₹231
New SL
250.0
ROHAN @rohan9401
May 29, 2020 8:01 AM

Update
Exited
Exit Price
₹251
Net P&L
+₹1,400 (+5.91%)
Recent posts in RPGLIFE
N
Reputation: -34,558 • Yesterday 3:43 AM

#RPGLIFE now trading at 393-394. Watch this for intraday and BTST

Please join my free telegram group : https://t.me/npgtradersfamily
Like
Reply (4)

Cmp 375
With closing basis SL 337
6 months target 420 447 465
Overall stock is very good for 460+ 500
In long term
Like
Reply
E
Reputation: -1,341 • Dec 11, 2020 3:53 AM

Type
Buy
Instrument
RPGLIFE
Entry Price
₹370  ₹375
Price@Trade
₹375
Target Price
₹405
Stop Price
₹335  ₹340
Valid Till
Jan 11, 2021 3:20 AM
Margin
₹10,875 approx for 29 Qty
Status
Exited
Exit Price
₹371
Net P&L
-₹116 (-1.07%)
Like
Reply (4)
E
Reputation: -1,341 • Dec 2, 2020 6:59 AM

Type
Buy
Instrument
RPGLIFE
Entry Price
₹368  ₹368.5
Price@Trade
₹367.8
Target Price
₹436
Stop Price
₹300
Valid Till
Dec 2, 2021 3:20 AM
Margin
₹49,747.5 approx for 135 Qty
Status
Exited
Exit Price
₹372.05
Net P&L
+₹479.25 (+0.96%)
Like
Reply (2)
A
Reputation: 1,332 • Nov 5, 2020 6:44 AM

Type
Buy
Instrument
RPGLIFE
Entry Price
₹362  ₹361.6
Price@Trade
₹362.75
Target Price
₹450
Stop Price
₹333
Valid Till
Nov 12, 2020 3:20 AM
Margin
₹72,320 approx for 200 Qty
Status
Exited
Exit Price
₹367.3
Net P&L
+₹1,140 (+1.58%)
Like
Reply (2)
N
Reputation: 10,319 • Nov 2, 2020 9:48 AM
RPG Life Sciences shifts gears, bets on chronic drugs to expand sales, profits
The drugmaker wants the chronic segment to account for 50 percent of revenue. Currently, RPG Life Sciences’ business mix is heavily skewed towards acute drugs, with over two-thirds of sales coming from this segment
Moneycontrol
Like
Reply